New Development of Biosimilars in US, including Immunotherapy agents for cancer, such as pembrolizumab

Name: New Development of Biosimilars in US, including Immunotherapy agents for cancer, such as pembrolizumab
Start: 2027-04-13T11:00
End: 2027-04-13
Location: Boston Convention & Exhibition Center (BCEC)

Festival of Biologics USA · 13 April 2027 · 11:00

New Development of Biosimilars in US, including Immunotherapy agents for cancer, such as pembrolizumab was a session at Festival of Biologics USA on 13 April 2027 in Boston, with 1 speaker on record.

Speakers

Sophia Humphreys — Speaker VP, Health System Strategy & Innovation, MJH Life Sciences